CA1050028A - Triazoles-1,2,4 substitues - Google Patents
Triazoles-1,2,4 substituesInfo
- Publication number
- CA1050028A CA1050028A CA222,366A CA222366A CA1050028A CA 1050028 A CA1050028 A CA 1050028A CA 222366 A CA222366 A CA 222366A CA 1050028 A CA1050028 A CA 1050028A
- Authority
- CA
- Canada
- Prior art keywords
- triazole
- compound
- whenever prepared
- obvious chemical
- carboxamido
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- -1 N-substituted 1,2,4-triazoles Chemical class 0.000 title claims abstract description 13
- 150000001875 compounds Chemical class 0.000 claims abstract description 38
- 125000005518 carboxamido group Chemical group 0.000 claims abstract description 16
- 238000006243 chemical reaction Methods 0.000 claims abstract description 9
- 125000004093 cyano group Chemical group *C#N 0.000 claims abstract description 9
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 8
- 230000007062 hydrolysis Effects 0.000 claims abstract description 8
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 8
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 7
- 239000012530 fluid Substances 0.000 claims abstract description 7
- 125000003258 trimethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])[*:1] 0.000 claims abstract description 6
- 230000000694 effects Effects 0.000 claims abstract description 5
- 150000002170 ethers Chemical class 0.000 claims abstract description 5
- 230000002496 gastric effect Effects 0.000 claims abstract description 5
- NSPMIYGKQJPBQR-UHFFFAOYSA-N 4H-1,2,4-triazole Chemical class C=1N=CNN=1 NSPMIYGKQJPBQR-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000002253 acid Substances 0.000 claims abstract description 4
- 238000007259 addition reaction Methods 0.000 claims abstract description 4
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 claims abstract description 4
- 238000000870 ultraviolet spectroscopy Methods 0.000 claims abstract description 3
- 238000000034 method Methods 0.000 claims description 33
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 12
- 125000005599 alkyl carboxylate group Chemical group 0.000 claims description 11
- BUDQDWGNQVEFAC-UHFFFAOYSA-N Dihydropyran Chemical compound C1COC=CC1 BUDQDWGNQVEFAC-UHFFFAOYSA-N 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- 125000004192 tetrahydrofuran-2-yl group Chemical group [H]C1([H])OC([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 5
- 125000004187 tetrahydropyran-2-yl group Chemical group [H]C1([H])OC([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 5
- FJKIXWOMBXYWOQ-UHFFFAOYSA-N ethenoxyethane Chemical compound CCOC=C FJKIXWOMBXYWOQ-UHFFFAOYSA-N 0.000 claims description 4
- LJVQHXICFCZRJN-UHFFFAOYSA-N 1h-1,2,4-triazole-5-carboxylic acid Chemical compound OC(=O)C1=NC=NN1 LJVQHXICFCZRJN-UHFFFAOYSA-N 0.000 claims description 3
- 239000012043 crude product Substances 0.000 claims description 3
- 238000002425 crystallisation Methods 0.000 claims description 3
- 230000008025 crystallization Effects 0.000 claims description 3
- GUQHFZFTGHNVDG-UHFFFAOYSA-N 1h-1,2,4-triazole-5-carbonitrile Chemical compound N#CC1=NC=NN1 GUQHFZFTGHNVDG-UHFFFAOYSA-N 0.000 claims description 2
- GXGJIOMUZAGVEH-UHFFFAOYSA-N Chamazulene Chemical group CCC1=CC=C(C)C2=CC=C(C)C2=C1 GXGJIOMUZAGVEH-UHFFFAOYSA-N 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- QMPFMODFBNEYJH-UHFFFAOYSA-N methyl 1h-1,2,4-triazole-5-carboxylate Chemical compound COC(=O)C1=NC=NN1 QMPFMODFBNEYJH-UHFFFAOYSA-N 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims 15
- RVKREWJCPIKDOG-UHFFFAOYSA-N 1-(oxolan-2-yl)-1,2,4-triazole-3-carboxamide Chemical compound N1=C(C(=O)N)N=CN1C1OCCC1 RVKREWJCPIKDOG-UHFFFAOYSA-N 0.000 claims 2
- HLAJNVDZTZOYTI-UHFFFAOYSA-N 2-(1-ethoxyethyl)-1,2,4-triazole-3-carboxamide Chemical compound CCOC(C)N1N=CN=C1C(N)=O HLAJNVDZTZOYTI-UHFFFAOYSA-N 0.000 claims 2
- NYMFNSGBZLNMDJ-UHFFFAOYSA-N 1-(1-ethoxyethyl)-1,2,4-triazole-3-carboxamide Chemical compound CCOC(C)N1C=NC(C(N)=O)=N1 NYMFNSGBZLNMDJ-UHFFFAOYSA-N 0.000 claims 1
- ZBJDITSTTJNTLF-UHFFFAOYSA-N 1-(oxan-2-yl)-1,2,4-triazole-3-carbonitrile Chemical compound N1=C(C#N)N=CN1C1OCCCC1 ZBJDITSTTJNTLF-UHFFFAOYSA-N 0.000 claims 1
- RSRHSSFKHOKRSX-UHFFFAOYSA-N 1-(oxan-2-yl)-1,2,4-triazole-3-carboxamide Chemical compound N1=C(C(=O)N)N=CN1C1OCCCC1 RSRHSSFKHOKRSX-UHFFFAOYSA-N 0.000 claims 1
- JKTCBAGSMQIFNL-UHFFFAOYSA-N 2,3-dihydrofuran Chemical compound C1CC=CO1 JKTCBAGSMQIFNL-UHFFFAOYSA-N 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 230000000840 anti-viral effect Effects 0.000 abstract description 4
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- 239000000047 product Substances 0.000 description 11
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 229940093499 ethyl acetate Drugs 0.000 description 8
- 235000019439 ethyl acetate Nutrition 0.000 description 8
- 239000002904 solvent Substances 0.000 description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 230000000975 bioactive effect Effects 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- ZEWJFUNFEABPGL-UHFFFAOYSA-N 1,2,4-triazole-3-carboxamide Chemical compound NC(=O)C=1N=CNN=1 ZEWJFUNFEABPGL-UHFFFAOYSA-N 0.000 description 2
- 150000000178 1,2,4-triazoles Chemical class 0.000 description 2
- SJCDBQHCQSIZHN-UHFFFAOYSA-N 1,2-dihydrotriazole-3-carboxamide Chemical compound NC(=O)N1NNC=C1 SJCDBQHCQSIZHN-UHFFFAOYSA-N 0.000 description 2
- SNTWKPAKVQFCCF-UHFFFAOYSA-N 2,3-dihydro-1h-triazole Chemical compound N1NC=CN1 SNTWKPAKVQFCCF-UHFFFAOYSA-N 0.000 description 2
- CBQYNPHHHJTCJS-UHFFFAOYSA-N Alline Chemical compound C1=CC=C2C3(O)CCN(C)C3NC2=C1 CBQYNPHHHJTCJS-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 238000007098 aminolysis reaction Methods 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- CYEBJEDOHLIWNP-UHFFFAOYSA-N methanethioamide Chemical compound NC=S CYEBJEDOHLIWNP-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000002777 nucleoside Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229940086542 triethylamine Drugs 0.000 description 2
- OQRXBXNATIHDQO-UHFFFAOYSA-N 6-chloropyridine-3,4-diamine Chemical compound NC1=CN=C(Cl)C=C1N OQRXBXNATIHDQO-UHFFFAOYSA-N 0.000 description 1
- 101150041968 CDC13 gene Proteins 0.000 description 1
- 101100289867 Mus musculus Lyl1 gene Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102100036286 Purine nucleoside phosphorylase Human genes 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- MHSVUSZEHNVFKW-UHFFFAOYSA-N bis-4-nitrophenyl phosphate Chemical compound C=1C=C([N+]([O-])=O)C=CC=1OP(=O)(O)OC1=CC=C([N+]([O-])=O)C=C1 MHSVUSZEHNVFKW-UHFFFAOYSA-N 0.000 description 1
- 238000010504 bond cleavage reaction Methods 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 150000004292 cyclic ethers Chemical class 0.000 description 1
- WJYHCYBNUJVCEH-UHFFFAOYSA-N cyclohexane;ethoxyethane Chemical compound CCOCC.C1CCCCC1 WJYHCYBNUJVCEH-UHFFFAOYSA-N 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- XONPDZSGENTBNJ-UHFFFAOYSA-N molecular hydrogen;sodium Chemical compound [Na].[H][H] XONPDZSGENTBNJ-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 108010009099 nucleoside phosphorylase Proteins 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000003586 protic polar solvent Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 150000008223 ribosides Chemical class 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 150000003852 triazoles Chemical group 0.000 description 1
- 239000005723 virus inoculator Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/056—Triazole or tetrazole radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/452,213 US3991078A (en) | 1971-06-01 | 1974-03-18 | N-substituted 1,2,4-triazoles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1050028A true CA1050028A (fr) | 1979-03-06 |
Family
ID=23795554
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA222,366A Expired CA1050028A (fr) | 1974-03-18 | 1975-03-18 | Triazoles-1,2,4 substitues |
Country Status (13)
| Country | Link |
|---|---|
| JP (2) | JPS50154252A (fr) |
| AR (1) | AR207138A1 (fr) |
| BE (2) | BE826777R (fr) |
| CA (1) | CA1050028A (fr) |
| DE (1) | DE2511829A1 (fr) |
| DK (1) | DK154343C (fr) |
| ES (1) | ES435690A2 (fr) |
| FR (1) | FR2264533B2 (fr) |
| GB (1) | GB1490272A (fr) |
| NL (1) | NL7503209A (fr) |
| SE (1) | SE7502994L (fr) |
| YU (1) | YU42138B (fr) |
| ZA (1) | ZA751663B (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02106421U (fr) * | 1989-02-07 | 1990-08-23 | ||
| RU2624018C2 (ru) * | 2016-09-26 | 2017-06-30 | Федеральное государственное бюджетное учреждение науки Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова РАН (ИБХ РАН) | Амид 5-(тетрагидрофуран-2-ил)-1,2,4-триазол-3-карбоновой кислоты, обладающий противовирусной активностью, и способ его получения |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3798209A (en) * | 1971-06-01 | 1974-03-19 | Icn Pharmaceuticals | 1,2,4-triazole nucleosides |
-
1975
- 1975-01-01 AR AR258017A patent/AR207138A1/es active
- 1975-03-14 GB GB10723/75A patent/GB1490272A/en not_active Expired
- 1975-03-17 SE SE7502994A patent/SE7502994L/xx unknown
- 1975-03-17 DK DK106475A patent/DK154343C/da not_active IP Right Cessation
- 1975-03-17 ES ES435690A patent/ES435690A2/es not_active Expired
- 1975-03-17 BE BE154412A patent/BE826777R/fr active
- 1975-03-18 YU YU658/75A patent/YU42138B/xx unknown
- 1975-03-18 FR FR7508455A patent/FR2264533B2/fr not_active Expired
- 1975-03-18 NL NL7503209A patent/NL7503209A/xx not_active Application Discontinuation
- 1975-03-18 DE DE19752511829 patent/DE2511829A1/de active Granted
- 1975-03-18 ZA ZA00751663A patent/ZA751663B/xx unknown
- 1975-03-18 CA CA222,366A patent/CA1050028A/fr not_active Expired
- 1975-03-18 JP JP50032821A patent/JPS50154252A/ja active Pending
-
1984
- 1984-02-02 JP JP59016195A patent/JPS59144773A/ja active Granted
-
1986
- 1986-01-31 BE BE0/216210A patent/BE904149Q/fr not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| BE826777R (fr) | 1975-07-16 |
| FR2264533B2 (fr) | 1978-09-01 |
| DK106475A (fr) | 1975-09-19 |
| JPS50154252A (fr) | 1975-12-12 |
| FR2264533A2 (fr) | 1975-10-17 |
| YU42138B (en) | 1988-06-30 |
| JPS6133822B2 (fr) | 1986-08-04 |
| ZA751663B (en) | 1976-02-25 |
| DK154343C (da) | 1989-05-22 |
| AR207138A1 (es) | 1976-09-15 |
| JPS59144773A (ja) | 1984-08-18 |
| DK154343B (da) | 1988-11-07 |
| YU65875A (en) | 1983-01-21 |
| AU7914475A (en) | 1976-09-23 |
| NL7503209A (nl) | 1975-09-22 |
| GB1490272A (en) | 1977-10-26 |
| DE2511829C2 (fr) | 1989-06-22 |
| DE2511829A1 (de) | 1975-09-25 |
| ES435690A2 (es) | 1977-02-01 |
| BE904149Q (fr) | 1986-05-15 |
| SE7502994L (fr) | 1975-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4843066A (en) | Novel adenosine derivatives and pharmaceutical composition containing them as an active ingredient | |
| US5945547A (en) | Imtermediate in process to make 2', 2'-difluoronucleosides | |
| US5075445A (en) | Guanine derivatives | |
| EP0003229B1 (fr) | Méthode de préparation de nucléosides | |
| IE36478B1 (en) | 1,2,4-triazole nucleosides | |
| US3984396A (en) | 1-(β,-D-ribofuranosyl)-1,2,4-triazole acid esters | |
| CH626093A5 (fr) | ||
| DE69308400T2 (de) | Verfahren zur Stereoselektivanionglycosylierung | |
| DE69109482T2 (de) | Pyrimidinnucleosidderivat. | |
| EP0165422B1 (fr) | Bis-(4-aminophényl)-sulfones substituées, leur préparation et leur utilisation comme médicaments | |
| EP0306190A2 (fr) | 2',2'-Difluoronucléosides | |
| WO1984000759A1 (fr) | Derives de desoxyuridine, leurs procedes de preparation et leur utilisation comme produits pharmaceutiques | |
| US3991078A (en) | N-substituted 1,2,4-triazoles | |
| US3721664A (en) | Preparation of 5-cytosine nucleosides | |
| DE69711868T2 (de) | Adenosin-derivate | |
| CA1102794A (fr) | Production de 2,6-diaminonebularines | |
| IL25712A (en) | 5',5'-dinucleoside phosphate | |
| CA1050028A (fr) | Triazoles-1,2,4 substitues | |
| GB2073752A (en) | 2,6-diaminobularines | |
| JP5550234B2 (ja) | フラノース誘導体の製造方法 | |
| DE68920648T2 (de) | Verfahren zur Herstellung von O2,2'-anhydro-1-(beta-D-arabinofuranosyl)Thymin. | |
| EP0638586A2 (fr) | Dérivés de nucléosides et leur préparation | |
| US3404144A (en) | 1-beta-d-arabinofuranosyl-5-fluorocytosine compounds | |
| CA1060004A (fr) | Esters de derives acides de 1-(b-d-ribofuranosyl)-1,2,4-triazoles | |
| US4751293A (en) | Process for preparation of N6 -substituted 3',5'-cyclic adenosine monophosphate and salt thereof |